AstraZeneca (NASDAQ: $AZN) posted its Q1 2025 earnings on April 29. The stock trades at $70.13. Revenue for the quarter rose 10% year-over-year to $13.59 […]
Category: Healthcare
UnitedHealth Group (NYSE: $UNH) Drops 22%+ After Q1 Earnings Miss and 2025 Guidance Cut
UnitedHealth Group (NYSE: $UNH) reported its first-quarter 2025 earnings, but the results and revised guidance disappointed investors. As of 12:47 PM EDT, the stock was […]
Abbott Laboratories (NYSE: $ABT) Releases Q1 Fiscal 2025 Results: Is ABT a Buy Amid Macroeconomic Headwinds?
Abbott Laboratories (NYSE: $ABT) announced Q1 fiscal 2025 results on Wednesday, April 16th. The healthcare firm posted $1.33 billion in net income. Adjusted earnings reached […]
Johnson & Johnson (NYSE: JNJ) Releases Q1 Fiscal 2025 Results: Is This Dividend Stock Still a Buy Amid Tariff Fears?
Johnson & Johnson (NYSE: $JNJ), a major multinational that produces medical devices and pharmaceuticals, released its first-quarter fiscal 2025 results on Tuesday, April 15, 2025, […]
OKYO Pharma (NASDAQ: OKYO) Reports Positive Stability Data For Urcosimod: Is Now The Time To Buy OKYO?
OKYO Pharma (NASDAQ: $OKYO), a clinical stage biopharmaceutical company, announced a major stability milestone for its drug candidate urcosimod on Monday, March 31, 2025. Details […]
Alvotech (NASDAQ: ALVO) Releases Q4 Fiscal 2024 Results: Is This Biotech A Buy in 2025?
Alvotech (NASDAQ: $ALVO), a leading global biopharmaceutical manufacturer of biosimilars, released its Q4 fiscal 2024 results on Wednesday, March 26, 2024, after markets closed. Here […]